STOCK TITAN

Cartier Silver Grants Stock Options

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Cartier Silver (CRTIF) granted stock options to directors, officers and consultants to buy 1,890,000 common shares at an exercise price of $0.20 per share. Options are exercisable anytime until April 2, 2031 and subject to the company's stock option plan.

According to the company, shares issued on exercise will carry a four-month resale restriction from the grant date to meet regulatory requirements.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Toronto, Ontario--(Newsfile Corp. - April 2, 2026) - Cartier Silver Corporation (CSE: CFE) ("Cartier Silver" or the "Company") announces the grant of stock options to directors, officers and consultants to purchase an aggregate of 1,890,000 common shares of the Company, exercisable at $0.20 per share at any time on or before April 2, 2031. The grants are subject to the terms of Cartier Silver's stock option plan. In accordance with regulatory requirements, any shares issued pursuant to the exercise of such options will be subject to a resale restriction for a period of four months from the date of the grant.

About Cartier Silver Corporation

Cartier Silver is an exploration and development Company focused on discovering and developing its silver property assets, including the Chorrillos Project and claims staked by the Company's subsidiary, all of which are located in the Potosi Department of southern Bolivia. The Company also holds significant iron ore resources at its Gagnon Holdings in the southern Labrador Trough region of east-central Quebec, and the Big Easy gold property in the Burin Peninsula epithermal gold belt in the Avalon Zone of eastern Newfoundland and Labrador.

For further information please visit Cartier Silver's website at www.cartiersilvercorp.com.

For further information please contact:

Thomas G. Larsen
Chief Executive Officer
(800) 360-8006
(416) 360-8006 
Jorge Estepa
Vice-President
(800) 360-8006
(416) 360-8006

 

The CSE has not reviewed nor accepts responsibility for the adequacy or accuracy of this release.

Statements in this release that are not historical facts are "forward-looking statements" and readers are cautioned that any such statements are not guarantees of future performance, and that actual developments or results, may vary materially from those in these "forward-looking statements".

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/291054

FAQ

What did Cartier Silver (CRTIF) announce on April 2, 2026 about stock options?

Cartier Silver granted options to buy 1,890,000 shares at $0.20, exercisable until April 2, 2031. According to the company, the grants follow the stock option plan and any shares issued on exercise will carry a four-month resale restriction from the grant date.

How long are Cartier Silver (CRTIF) stock options exercisable after the April 2, 2026 grant?

The options are exercisable at any time up to April 2, 2031, a five-year term. According to the company, the exercise price is $0.20 per share and the grants are governed by Cartier Silver's stock option plan.

What is the exercise price for the Cartier Silver (CRTIF) options granted April 2, 2026?

The exercise price is $0.20 per share for the 1,890,000 options granted. According to the company, exercised shares will be subject to a four-month resale restriction from the grant date under applicable regulatory rules.

Who received the Cartier Silver (CRTIF) option grants announced April 2, 2026?

Options were granted to directors, officers and consultants of Cartier Silver. According to the company, the aggregate number of options is 1,890,000 and the awards are subject to the company's stock option plan and resale restrictions.

Will shares from Cartier Silver (CRTIF) option exercises be restricted after the April 2, 2026 grant?

Yes. Shares issued on exercise will be subject to a four-month resale restriction from the grant date. According to the company, this restriction is applied to meet regulatory requirements following the option grants.